BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 15239085)

  • 1. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
    Hui JM; Hodge A; Farrell GC; Kench JG; Kriketos A; George J
    Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
    Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
    Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
    Wong VW; Wong GL; Yu J; Choi PC; Chan AW; Chan HY; Chu ES; Cheng AS; Chim AM; Chan FK; Sung JJ; Chan HL
    Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease.
    Musso G; Gambino R; Durazzo M; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Rabbione L; Premoli A; Cassader M; Pagano G
    Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.
    Shimada M; Kawahara H; Ozaki K; Fukura M; Yano H; Tsuchishima M; Tsutsumi M; Takase S
    Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis.
    Tokushige K; Takakura M; Tsuchiya-Matsushita N; Taniai M; Hashimoto E; Shiratori K
    J Hepatol; 2007 Jun; 46(6):1104-10. PubMed ID: 17395331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
    Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
    Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.
    Crespo J; Cayón A; Fernández-Gil P; Hernández-Guerra M; Mayorga M; Domínguez-Díez A; Fernández-Escalante JC; Pons-Romero F
    Hepatology; 2001 Dec; 34(6):1158-63. PubMed ID: 11732005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
    Abiru S; Migita K; Maeda Y; Daikoku M; Ito M; Ohata K; Nagaoka S; Matsumoto T; Takii Y; Kusumoto K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
    Liver Int; 2006 Feb; 26(1):39-45. PubMed ID: 16420507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
    Ohya M; Taniguchi A; Fukushima M; Nakai Y; Kawasaki Y; Nagasaka S; Kuroe A; Taki Y; Yoshii S; Hosokawa M; Inagaki N; Seino Y
    Metabolism; 2005 Oct; 54(10):1297-301. PubMed ID: 16154427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy.
    Stejskal D; Růzicka V; Fanfrdlová G; Kolár V; Bartek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):93-9. PubMed ID: 16170395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis.
    Musso G; Gambino R; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Cassader M; Durazzo M; Rizzetto M; Pagano G
    Am J Gastroenterol; 2005 Nov; 100(11):2438-46. PubMed ID: 16279898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.
    Haukeland JW; Damås JK; Konopski Z; Løberg EM; Haaland T; Goverud I; Torjesen PA; Birkeland K; Bjøro K; Aukrust P
    J Hepatol; 2006 Jun; 44(6):1167-74. PubMed ID: 16618517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
    Kamada Y; Matsumoto H; Tamura S; Fukushima J; Kiso S; Fukui K; Igura T; Maeda N; Kihara S; Funahashi T; Matsuzawa Y; Shimomura I; Hayashi N
    J Hepatol; 2007 Oct; 47(4):556-64. PubMed ID: 17459514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.